The global Naloxegol market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
The U.S. market is estimated at $ million in 2024, while China is to reach $ million.
Tablet segment will reach $ million by 2032, with a % CAGR in next six years.
The global key players of Naloxegol include MOVANTIK, AstraZeneca, Aurobindo, MSN Life Sciences, Lepu, Daiichi Sankyo Company, Knight Therapeutics, Kyowa Kirin International, Nektar Therapeutics, RedHill Biopharma Ltd., etc. In 2024, the global top five players had a share approximately % in terms of revenue.
We have surveyed the Naloxegol companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Naloxegol, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Naloxegol. This report contains market size and forecasts of Naloxegol in global, including the following market information:
Global Naloxegol market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Naloxegol companies in 2024 (%)
Total Market by Segment:
Global Naloxegol market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Naloxegol market segment percentages, by Type, 2024 (%)
Tablet
Capsule
Global Naloxegol market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Naloxegol market segment percentages, by Application, 2024 (%)
Pharmacy
Hospital
Clinic
Others
Global Naloxegol market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Naloxegol market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Naloxegol revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Naloxegol revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
MOVANTIK
AstraZeneca
Aurobindo
MSN Life Sciences
Lepu
Daiichi Sankyo Company
Knight Therapeutics
Kyowa Kirin International
Nektar Therapeutics
RedHill Biopharma Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Naloxegol, market overview.
Chapter 2: Global Naloxegol market size in revenue.
Chapter 3: Detailed analysis of Naloxegol company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Naloxegol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Naloxegol Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Naloxegol Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Naloxegol Overall Market Size
2.1 Global Naloxegol Market Size: 2024 VS 2032
2.2 Global Naloxegol Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Naloxegol Players in Global Market
3.2 Top Global Naloxegol Companies Ranked by Revenue
3.3 Global Naloxegol Revenue by Companies
3.4 Top 3 and Top 5 Naloxegol Companies in Global Market, by Revenue in 2024
3.5 Global Companies Naloxegol Product Type
3.6 Tier 1, Tier 2, and Tier 3 Naloxegol Players in Global Market
3.6.1 List of Global Tier 1 Naloxegol Companies
3.6.2 List of Global Tier 2 and Tier 3 Naloxegol Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Naloxegol Market Size Markets, 2024 & 2032
4.1.2 Tablet
4.1.3 Capsule
4.2 Segmentation by Type - Global Naloxegol Revenue & Forecasts
4.2.1 Segmentation by Type - Global Naloxegol Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Naloxegol Revenue, 2026-2032
4.2.3 Segmentation by Type - Global Naloxegol Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Naloxegol Market Size, 2024 & 2032
5.1.2 Pharmacy
5.1.3 Hospital
5.1.4 Clinic
5.1.5 Others
5.2 Segmentation by Application - Global Naloxegol Revenue & Forecasts
5.2.1 Segmentation by Application - Global Naloxegol Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Naloxegol Revenue, 2026-2032
5.2.3 Segmentation by Application - Global Naloxegol Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global Naloxegol Market Size, 2024 & 2032
6.2 By Region - Global Naloxegol Revenue & Forecasts
6.2.1 By Region - Global Naloxegol Revenue, 2020-2025
6.2.2 By Region - Global Naloxegol Revenue, 2026-2032
6.2.3 By Region - Global Naloxegol Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America Naloxegol Revenue, 2020-2032
6.3.2 United States Naloxegol Market Size, 2020-2032
6.3.3 Canada Naloxegol Market Size, 2020-2032
6.3.4 Mexico Naloxegol Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe Naloxegol Revenue, 2020-2032
6.4.2 Germany Naloxegol Market Size, 2020-2032
6.4.3 France Naloxegol Market Size, 2020-2032
6.4.4 U.K. Naloxegol Market Size, 2020-2032
6.4.5 Italy Naloxegol Market Size, 2020-2032
6.4.6 Russia Naloxegol Market Size, 2020-2032
6.4.7 Nordic Countries Naloxegol Market Size, 2020-2032
6.4.8 Benelux Naloxegol Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia Naloxegol Revenue, 2020-2032
6.5.2 China Naloxegol Market Size, 2020-2032
6.5.3 Japan Naloxegol Market Size, 2020-2032
6.5.4 South Korea Naloxegol Market Size, 2020-2032
6.5.5 Southeast Asia Naloxegol Market Size, 2020-2032
6.5.6 India Naloxegol Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America Naloxegol Revenue, 2020-2032
6.6.2 Brazil Naloxegol Market Size, 2020-2032
6.6.3 Argentina Naloxegol Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Naloxegol Revenue, 2020-2032
6.7.2 Turkey Naloxegol Market Size, 2020-2032
6.7.3 Israel Naloxegol Market Size, 2020-2032
6.7.4 Saudi Arabia Naloxegol Market Size, 2020-2032
6.7.5 UAE Naloxegol Market Size, 2020-2032
7 Companies Profiles
7.1 MOVANTIK
7.1.1 MOVANTIK Corporate Summary
7.1.2 MOVANTIK Business Overview
7.1.3 MOVANTIK Naloxegol Major Product Offerings
7.1.4 MOVANTIK Naloxegol Revenue in Global Market (2020-2025)
7.1.5 MOVANTIK Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Corporate Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Naloxegol Major Product Offerings
7.2.4 AstraZeneca Naloxegol Revenue in Global Market (2020-2025)
7.2.5 AstraZeneca Key News & Latest Developments
7.3 Aurobindo
7.3.1 Aurobindo Corporate Summary
7.3.2 Aurobindo Business Overview
7.3.3 Aurobindo Naloxegol Major Product Offerings
7.3.4 Aurobindo Naloxegol Revenue in Global Market (2020-2025)
7.3.5 Aurobindo Key News & Latest Developments
7.4 MSN Life Sciences
7.4.1 MSN Life Sciences Corporate Summary
7.4.2 MSN Life Sciences Business Overview
7.4.3 MSN Life Sciences Naloxegol Major Product Offerings
7.4.4 MSN Life Sciences Naloxegol Revenue in Global Market (2020-2025)
7.4.5 MSN Life Sciences Key News & Latest Developments
7.5 Lepu
7.5.1 Lepu Corporate Summary
7.5.2 Lepu Business Overview
7.5.3 Lepu Naloxegol Major Product Offerings
7.5.4 Lepu Naloxegol Revenue in Global Market (2020-2025)
7.5.5 Lepu Key News & Latest Developments
7.6 Daiichi Sankyo Company
7.6.1 Daiichi Sankyo Company Corporate Summary
7.6.2 Daiichi Sankyo Company Business Overview
7.6.3 Daiichi Sankyo Company Naloxegol Major Product Offerings
7.6.4 Daiichi Sankyo Company Naloxegol Revenue in Global Market (2020-2025)
7.6.5 Daiichi Sankyo Company Key News & Latest Developments
7.7 Knight Therapeutics
7.7.1 Knight Therapeutics Corporate Summary
7.7.2 Knight Therapeutics Business Overview
7.7.3 Knight Therapeutics Naloxegol Major Product Offerings
7.7.4 Knight Therapeutics Naloxegol Revenue in Global Market (2020-2025)
7.7.5 Knight Therapeutics Key News & Latest Developments
7.8 Kyowa Kirin International
7.8.1 Kyowa Kirin International Corporate Summary
7.8.2 Kyowa Kirin International Business Overview
7.8.3 Kyowa Kirin International Naloxegol Major Product Offerings
7.8.4 Kyowa Kirin International Naloxegol Revenue in Global Market (2020-2025)
7.8.5 Kyowa Kirin International Key News & Latest Developments
7.9 Nektar Therapeutics
7.9.1 Nektar Therapeutics Corporate Summary
7.9.2 Nektar Therapeutics Business Overview
7.9.3 Nektar Therapeutics Naloxegol Major Product Offerings
7.9.4 Nektar Therapeutics Naloxegol Revenue in Global Market (2020-2025)
7.9.5 Nektar Therapeutics Key News & Latest Developments
7.10 RedHill Biopharma Ltd.
7.10.1 RedHill Biopharma Ltd. Corporate Summary
7.10.2 RedHill Biopharma Ltd. Business Overview
7.10.3 RedHill Biopharma Ltd. Naloxegol Major Product Offerings
7.10.4 RedHill Biopharma Ltd. Naloxegol Revenue in Global Market (2020-2025)
7.10.5 RedHill Biopharma Ltd. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Naloxegol Market Opportunities & Trends in Global Market
Table 2. Naloxegol Market Drivers in Global Market
Table 3. Naloxegol Market Restraints in Global Market
Table 4. Key Players of Naloxegol in Global Market
Table 5. Top Naloxegol Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Naloxegol Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Naloxegol Revenue Share by Companies, 2020-2025
Table 8. Global Companies Naloxegol Product Type
Table 9. List of Global Tier 1 Naloxegol Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Naloxegol Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global Naloxegol Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Naloxegol Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Naloxegol Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global Naloxegol Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Naloxegol Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Naloxegol Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global Naloxegol Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Naloxegol Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Naloxegol Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Naloxegol Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Naloxegol Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Naloxegol Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Naloxegol Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Naloxegol Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Naloxegol Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Naloxegol Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Naloxegol Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Naloxegol Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Naloxegol Revenue, (US$, Mn), 2026-2032
Table 30. MOVANTIK Corporate Summary
Table 31. MOVANTIK Naloxegol Product Offerings
Table 32. MOVANTIK Naloxegol Revenue (US$, Mn) & (2020-2025)
Table 33. MOVANTIK Key News & Latest Developments
Table 34. AstraZeneca Corporate Summary
Table 35. AstraZeneca Naloxegol Product Offerings
Table 36. AstraZeneca Naloxegol Revenue (US$, Mn) & (2020-2025)
Table 37. AstraZeneca Key News & Latest Developments
Table 38. Aurobindo Corporate Summary
Table 39. Aurobindo Naloxegol Product Offerings
Table 40. Aurobindo Naloxegol Revenue (US$, Mn) & (2020-2025)
Table 41. Aurobindo Key News & Latest Developments
Table 42. MSN Life Sciences Corporate Summary
Table 43. MSN Life Sciences Naloxegol Product Offerings
Table 44. MSN Life Sciences Naloxegol Revenue (US$, Mn) & (2020-2025)
Table 45. MSN Life Sciences Key News & Latest Developments
Table 46. Lepu Corporate Summary
Table 47. Lepu Naloxegol Product Offerings
Table 48. Lepu Naloxegol Revenue (US$, Mn) & (2020-2025)
Table 49. Lepu Key News & Latest Developments
Table 50. Daiichi Sankyo Company Corporate Summary
Table 51. Daiichi Sankyo Company Naloxegol Product Offerings
Table 52. Daiichi Sankyo Company Naloxegol Revenue (US$, Mn) & (2020-2025)
Table 53. Daiichi Sankyo Company Key News & Latest Developments
Table 54. Knight Therapeutics Corporate Summary
Table 55. Knight Therapeutics Naloxegol Product Offerings
Table 56. Knight Therapeutics Naloxegol Revenue (US$, Mn) & (2020-2025)
Table 57. Knight Therapeutics Key News & Latest Developments
Table 58. Kyowa Kirin International Corporate Summary
Table 59. Kyowa Kirin International Naloxegol Product Offerings
Table 60. Kyowa Kirin International Naloxegol Revenue (US$, Mn) & (2020-2025)
Table 61. Kyowa Kirin International Key News & Latest Developments
Table 62. Nektar Therapeutics Corporate Summary
Table 63. Nektar Therapeutics Naloxegol Product Offerings
Table 64. Nektar Therapeutics Naloxegol Revenue (US$, Mn) & (2020-2025)
Table 65. Nektar Therapeutics Key News & Latest Developments
Table 66. RedHill Biopharma Ltd. Corporate Summary
Table 67. RedHill Biopharma Ltd. Naloxegol Product Offerings
Table 68. RedHill Biopharma Ltd. Naloxegol Revenue (US$, Mn) & (2020-2025)
Table 69. RedHill Biopharma Ltd. Key News & Latest Developments
List of Figures
Figure 1. Naloxegol Product Picture
Figure 2. Naloxegol Segment by Type in 2024
Figure 3. Naloxegol Segment by Application in 2024
Figure 4. Global Naloxegol Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Naloxegol Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Naloxegol Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Naloxegol Revenue in 2024
Figure 9. Segmentation by Type � Global Naloxegol Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Naloxegol Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global Naloxegol Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Naloxegol Revenue Market Share, 2020-2032
Figure 13. By Region - Global Naloxegol Revenue Market Share, 2020-2032
Figure 14. By Country - North America Naloxegol Revenue Market Share, 2020-2032
Figure 15. United States Naloxegol Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Naloxegol Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Naloxegol Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Naloxegol Revenue Market Share, 2020-2032
Figure 19. Germany Naloxegol Revenue, (US$, Mn), 2020-2032
Figure 20. France Naloxegol Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Naloxegol Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Naloxegol Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Naloxegol Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Naloxegol Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Naloxegol Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Naloxegol Revenue Market Share, 2020-2032
Figure 27. China Naloxegol Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Naloxegol Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Naloxegol Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Naloxegol Revenue, (US$, Mn), 2020-2032
Figure 31. India Naloxegol Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Naloxegol Revenue Market Share, 2020-2032
Figure 33. Brazil Naloxegol Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Naloxegol Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Naloxegol Revenue Market Share, 2020-2032
Figure 36. Turkey Naloxegol Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Naloxegol Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Naloxegol Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Naloxegol Revenue, (US$, Mn), 2020-2032
Figure 40. MOVANTIK Naloxegol Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. AstraZeneca Naloxegol Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Aurobindo Naloxegol Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. MSN Life Sciences Naloxegol Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Lepu Naloxegol Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Daiichi Sankyo Company Naloxegol Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Knight Therapeutics Naloxegol Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Kyowa Kirin International Naloxegol Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Nektar Therapeutics Naloxegol Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. RedHill Biopharma Ltd. Naloxegol Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
